ProteoNic Announces Licensing of its 2G UNic Technology Platform for Production of Biologics to GenScript ProBio

LEIDEN, Netherlands, June 15, 2022 /PRNewswire/ -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, today announced licensing

Related Keywords

Boston ,Massachusetts ,United States ,Netherlands ,Mark Posno ,Frank Pieper ,Genscript Probio ,Shanlin Yang ,Genscript Biotech Corporation ,Business Development ,Brian Min ,Script Probio ,Proteonic ,Nnounces ,Icensing ,Nic ,Technology ,Platform ,Production ,Iologics ,Genscript ,Avrobio ,